- Company Overview for CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED (09686738)
- Filing history for CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED (09686738)
- People for CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED (09686738)
- Charges for CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED (09686738)
- More for CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED (09686738)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
22 Sep 2017 | RESOLUTIONS |
Resolutions
|
|
25 Jul 2017 | CS01 | Confirmation statement made on 14 July 2017 with updates | |
22 May 2017 | TM01 | Termination of appointment of Andrew Peter Walsh as a director on 15 May 2017 | |
22 May 2017 | AP01 | Appointment of Dr Anne Michelle Dobrée as a director on 15 May 2017 | |
28 Apr 2017 | RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 3 November 2015
|
|
12 Apr 2017 | AA | Total exemption small company accounts made up to 31 July 2016 | |
20 Dec 2016 | SH08 | Change of share class name or designation | |
23 Sep 2016 | CH01 | Director's details changed for Dr Kevin Stuart Johnson on 20 September 2016 | |
23 Sep 2016 | CH01 | Director's details changed for Dr David John Grainger on 20 September 2016 | |
18 Jul 2016 | CS01 | Confirmation statement made on 14 July 2016 with updates | |
25 Jan 2016 | AD01 | Registered office address changed from C/O Index Ventures (Uk) Llp 3 Burlington Gardens Mayfair London W1S 3EP England to Moneta Building Babraham Research Campus Cambridge CB22 3AT on 25 January 2016 | |
20 Jan 2016 | AP01 | Appointment of Kevin Stuart Johnson as a director on 30 October 2015 | |
18 Jan 2016 | SH01 |
Statement of capital following an allotment of shares on 27 November 2015
|
|
28 Nov 2015 | AP01 | Appointment of Andrew Peter Walsh as a director on 30 October 2015 | |
28 Nov 2015 | AP01 | Appointment of Dr Robert Giles Tansley as a director on 30 October 2015 | |
26 Nov 2015 | AP01 | Appointment of Professor Nicholas Morrell as a director on 30 October 2015 | |
24 Nov 2015 | SH01 |
Statement of capital following an allotment of shares on 3 November 2015
|
|
24 Nov 2015 | SH08 | Change of share class name or designation | |
24 Nov 2015 | RESOLUTIONS |
Resolutions
|
|
15 Jul 2015 | NEWINC |
Incorporation
Statement of capital on 2015-07-15
|